🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Vaxcell-Bio Therapeutics Co., Ltd. (KOSDAQ:323990)
South Korea flag South Korea · Delayed Price · Currency is KRW
3,515.00
-200.00 (-5.38%)
Nov 20, 2026, 3:30 PM KST

Vaxcell-Bio Therapeutics Market Cap

Vaxcell-Bio Therapeutics has a market cap or net worth of 81.75 billion as of November 20, 2026. It is the 28,089th most valuable company in the world and the 1,317th biggest in South Korea. Its market cap has decreased by 63.12% in one year.

Market Cap
81.75B
Enterprise Value
43.71B
Revenue
n/a
Global Rank
Country Rank
#1,317 South Korea
PE Ratio
n/a

Chart

Chart

Since September 22, 2020, Vaxcell-Bio Therapeutics's market cap has decreased from 160.24B to 81.75B, a decrease of -48.98%. That is a compound annual growth rate of -10.34%.

History

DateMarket Cap% Change
Nov 20, 202681.75B-64.81%
Dec 30, 2025232.34B-3.12%
Dec 30, 2024239.82B-53.54%
Dec 28, 2023516.20B-0.71%
Dec 29, 2022519.87B-21.31%
Dec 30, 2021660.68B-73.75%
Dec 30, 2020 Pro Pro
Sep 22, 2020 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Related Stocks

CompanyMarket Cap
GC Cell148.32B
Helixmith146.20B
NeoImmuneTech139.40B
Anterogen.Co.,Ltd.129.88B
MedPacto125.28B
HLB Therapeutics102.77B
Genexine80.77B
iNtRON Biotechnology76.77B
Market Cap Rankings